Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,431,191
-$444,140 QoQ
Shares Held
47,417
-8.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#210
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fiduciary Trust Co holds $270,904,336 across 13 Drug Manufacturers - General names. NVS ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
317,105 | $80,535,156 | |
| 2 | ABBV |
AbbVie Inc.
|
303,294 | $76,320,901 | |
| 3 | MRK |
Merck & Co., Inc.
|
401,189 | $51,552,786 | |
| 4 | AMGN |
Amgen Inc
|
49,645 | $17,977,447 | |
| 5 | LLY |
ELI LILLY & Co
|
13,964 | $16,748,840 | |
| 6 | NVS |
Novartis AG
This page
|
47,417 | $7,431,191 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
120,039 | $6,916,646 | |
| 8 | PFE |
Pfizer Inc
|
251,314 | $6,051,640 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,431,191 | 47,417 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,875,331 | 51,557 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,668,053 | 55,618 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,416,503 | 57,833 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,017,974 | 57,995 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,624,475 | 59,423 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,822,488 | 49,558 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,746,054 | 49,957 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,254,545 | 49,357 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,052,594 | 52,234 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,283,759 | 52,330 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $5,401,431 | 53,028 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,406,050 | 53,573 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $5,089,808 | 55,324 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,177,027 | 57,066 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,437,843 | 58,385 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,887,185 | 57,816 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,149,696 | 58,686 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $5,437,046 | 62,159 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,513,852 | 67,423 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,992,998 | 76,644 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,823,812 | 91,528 | Shares | Sole | 2021-05-19 | |
| 2020-12-31 | $8,809,185 | 93,288 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $8,908,442 | 102,443 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $9,074,800 | 103,902 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,693,939 | 105,445 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||